ArticleClinicoEconomics and outcomes research : CEOR2025

Analysis of Cost-Effectiveness of Biologic Therapies in Axial Spondyloarthritis Based on Real-World Data.

Jamal Al-Saleh et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.